Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS studyJosé Luis Fernández Martín, Jorge B. Cannata‐Andía, Pablo Martínez‐Camblor et al.|Nephrology Dialysis Transplantation|2015Cited by 201
Use of phosphate-binding agents is associated with a lower risk of mortalityJorge B. Cannata‐Andía, Carmine Zoccali, José Luis Fernández Martín et al.|Kidney International|2013Cited by 158
DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer SubtypesSandra Rodríguez‐Rodero, Mario F. Fraga, Agustín F. Fernández et al.|The Journal of Clinical Endocrinology & Metabolism|2013Cited by 122
COSMOS: the dialysis scenario of CKD–MBD in EuropeJosé Luis Fernández Martín, Jorge B. Cannata‐Andía, Juan Jesús Carrero et al.|Nephrology Dialysis Transplantation|2012Cited by 92
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS studyJosé Luis Fernández Martín, S. Croft, Adriana Dusso et al.|Nephrology Dialysis Transplantation|2018Cited by 33